Topics

BioNTech Falls Short In Jittery IPO Market

23:16 EDT 10 Oct 2019 | SCRIP

After ADC Therapeutics postponed its launch last week, BioNTech braves the markets but finds them less receptive than hoped.

      

Related Stories

 

Original Article: BioNTech Falls Short In Jittery IPO Market

NEXT ARTICLE

More From BioPortfolio on "BioNTech Falls Short In Jittery IPO Market"

Quick Search